| abstract |
The present invention relates to a compound of formula (I), a method for preparing the same, a pharmaceutical composition containing the same, and a use thereof as a dual modulator of serotonin 5-HT 2A and dopamine D 3 receptor. Compounds of Formula 1 have high affinity for dopamine D 3 and serotonin (5-hydroxytrytamine; 5-HT) 5-HT 2A receptors and have psychotic disorders and depression and anxiety, drug dependence, dementia and memory damage It is effective in the treatment of other disorders such as: Formula 1 In this formula, R 1 , R 2 , X and n are as defined in the specification. |